MX2019002349A - Anticuerpos inmunomoduladores biespecíficos que se fijan a receptores coestimuladores y de puntos de control. - Google Patents

Anticuerpos inmunomoduladores biespecíficos que se fijan a receptores coestimuladores y de puntos de control.

Info

Publication number
MX2019002349A
MX2019002349A MX2019002349A MX2019002349A MX2019002349A MX 2019002349 A MX2019002349 A MX 2019002349A MX 2019002349 A MX2019002349 A MX 2019002349A MX 2019002349 A MX2019002349 A MX 2019002349A MX 2019002349 A MX2019002349 A MX 2019002349A
Authority
MX
Mexico
Prior art keywords
immunomodulatory antibodies
checkpoint receptors
bind costimulatory
bispecific immunomodulatory
bispecific
Prior art date
Application number
MX2019002349A
Other languages
English (en)
Inventor
Bernett Matthew
Moore Gregory
Desjarlais John
Hedvat Michael
Bonzon Christine
Original Assignee
Xencor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/623,314 external-priority patent/US10787518B2/en
Application filed by Xencor Inc filed Critical Xencor Inc
Priority claimed from PCT/US2017/049497 external-priority patent/WO2018045110A1/en
Publication of MX2019002349A publication Critical patent/MX2019002349A/es

Links

Abstract

La presente invención se refiere a anticuerpos inmunomoduladores, heterodiméricos y biespecíficos.
MX2019002349A 2016-08-30 2017-08-30 Anticuerpos inmunomoduladores biespecíficos que se fijan a receptores coestimuladores y de puntos de control. MX2019002349A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662381239P 2016-08-30 2016-08-30
US201762456033P 2017-02-07 2017-02-07
US15/623,314 US10787518B2 (en) 2016-06-14 2017-06-14 Bispecific checkpoint inhibitor antibodies
PCT/US2017/049497 WO2018045110A1 (en) 2016-08-30 2017-08-30 Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
US201862479723P 2018-03-31 2018-03-31

Publications (1)

Publication Number Publication Date
MX2019002349A true MX2019002349A (es) 2019-08-29

Family

ID=68579225

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002349A MX2019002349A (es) 2016-08-30 2017-08-30 Anticuerpos inmunomoduladores biespecíficos que se fijan a receptores coestimuladores y de puntos de control.

Country Status (1)

Country Link
MX (1) MX2019002349A (es)

Similar Documents

Publication Publication Date Title
MX2018015592A (es) Anticuerpos inhibidores de puntos de control biespecificos.
CY1124993T1 (el) Ετεροδιμερικα αντισωματα που δεσμευουν cd3 και cd20
AU2018366199A1 (en) Bispecific and monospecific antibodies using novel anti-PD-1 sequences
PH12017502019A1 (en) Heterodimeric antibodies that bind cd3 and tumor antigens
CY1123236T1 (el) Αντισωματα διπλης εξειδικευσης που δεσμευονται με cd38 και cd3
PH12017500982A1 (en) Heterodimeric antibodies that bind cd3 and cd38
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
MX2020009649A (es) Anticuerpos monoclonales contra bcma.
MX2022002364A (es) Anticuerpos anti-pd-l1.
MX2018008369A (es) Anticuerpos de anti-miostatina pro/latente y metodo de uso de los mismos.
MX2015013901A (es) Anticuerpos anti-il-4 y anticuerpos biespecificos y sus usos.
PE20210648A1 (es) Anticuerpos anti-cd3 y metodos de uso
MX2017007491A (es) Anticuerpos del receptor de la barrera hematoencefálica y métodos para su uso.
MX2023006786A (es) Anticuerpos inmunomoduladores biespecificos que se fijan a receptores coestimuladores y de puntos de control.
PH12019501605A1 (en) Glucagon receptor binding proteins and methods of use thereof
NZ739560A (en) Novel anti-human gpvi antibodies and uses thereof
MX2019002349A (es) Anticuerpos inmunomoduladores biespecíficos que se fijan a receptores coestimuladores y de puntos de control.
MX2018009218A (es) Anticuerpos de cgrp y sus usos.